Vaginal retention of locally administered clindamycin

APMIS

Volumn 119, Issue 6, 2011, Pages 373-376

  Eriksson, Katarina ^a,b   Larsson, Per Göran ^b,c   Nilsson, Maud ^b   Forsum, Urban ^b  

^a Ålands Centralsjukhus ^*  (Finland)

^b LINKÖPING UNIVERSITY   (Sweden)

^c UNIVERSITY OF SKÖVDE   (Sweden)

Author keywords

Bacterial vaginosis; Clindamycin; Concentration; Treatment

Indexed keywords

CLINDAMYCIN; PROBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; DRUG DETERMINATION; DRUG INDICATION; FEMALE; HUMAN; LACTOBACILLUS; PRIORITY JOURNAL; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ADULT; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LACTOBACILLUS; MIDDLE AGED; PROBIOTICS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VAGINA; VAGINOSIS, BACTERIAL;

EID: 79955952810     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2011.02742.x     Document Type: Article

References (12)

1. Oduyebo OO, Anorlu RI, Ogunsola FT. The effects of antimicrobial therapy on bacterial vaginosis in non-pregnant women. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CDOO6055. Doi:.
2. Verstraelen H, Verhelst R. Bacterial vaginosis: an update on diagnosis and treatment. Expert Rev Anti Infect Ther 2009;7:1109-24.
3. Forsum U, Hallen A, Larsson PG. Bacterial vaginosis - a laboratory and clinical diagnostics enigma. APMIS 2005;113:153-61.
4. Hillier S, Krohn MA, Watts DH, Wolner-Hanssen P, Eschenbach D. Microbiologic efficacy of intravaginal clindamycin cream for the treatment of bacterial vaginosis. Obstet Gynecol 1990;76:407-13.
5. Senok AC, Verstraelen H, Temmerman M, Botta GA. Probiotics for the treatment of bacterial vaginosis. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD006289. Doi:.
6. Borin MT. Systemic absorption of clindamycin following intravaginal application of clindamycin phosphate 1% cream. J Clin Pharmacol 1990;30:33-8.
7. Borin MT, Ryan KK, Hopkins NK. Systemic absorption of clindamycin after intravaginal administration of clindamycin phosphate ovule or cream. J Clin Pharmacol 1999;39:805-10.
8. Borin MT, Powley GW, Tackwell KR, Batts DH. Absorption of clindamycin after intravaginal application of clindamycin phosphate 2% cream. J Antimicrob Chemother 1995;35:833-41.
9. Levinson RS, Mitan SJ, Steinmetz JI, Gattermeir DJ, Schumacher RJ, Joffrion JL. An open-label, two-period, crossover study of the systemic bioavailability in healthy women of clindamycin phosphate from two vaginal cream formulations. Clin Ther 2005;27:1894-900.
10. Amsel R, Totten PA, Spiegel CA, Chen K, Eschenbach DA, Holmes KK. Nonspecific vaginitis. Diagnostic criteria and microbial and epidemiologic associations. Am J Med 1983;74:14-22.
11. Cars O, Henning C, Holm SE. Penetration of ampicillin and dicloxacillin into tissue cage fluid in rabbits: relation to serum and tissue protein bin ding. Scand J Infect Dis 1981;13:69-74.
12. Beigi RH, Austin MN, Meyn LA, Krohn MA, Hillier SL. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 2004;191:1124-9.